Perioperative Aspirin Usage Survey

Use of Aspirin in the Perioperative Setting: A Surgeon's Survey

This is a survey of members of the American College of Surgeons (ACS), to describe and explore current patterns of their decisions about withholding or continuation for patients taking aspirin (ASA) in the perioperative period. Secondarily, the survey will also explore surgeons' knowledge about the risks and benefits attending this decision, and about national organizations' recommendations.

Study Overview

• Status: Terminated
• Conditions: Cardiovascular Disease; Surgery
• Intervention / Treatment: Behavioral: Survey

Detailed Description

An announcement of the survey and invitation to participate will be posted in the "ACS Surgery News" newsletter published by the American College of Surgeons. Surgeons of all specialties will be invited to participate. No identifiers will be maintained with survey responses. In addition to the substantive questions below, typical demographic data will be obtained including participants' duration of practice, specialty, gender, state, etc.

The survey will include questions intended to characterize current practice surrounding the decision to continue or withhold aspirin in the perioperative period. Other questions will focus on surgeons' knowledge of national medical/surgical organizations that have published guidelines on the perioperative use of aspirin. Finally, other survey questions will characterize surgeons' knowledge of the platelet rebound effect.

• Study Type: Observational
• Enrollment (Actual): 150

Contacts and Locations

Study Locations

• United States
  • New Mexico
    • Albuquerque, New Mexico, United States, 87106
      • University of New Mexico Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes

• Sampling Method: Non-Probability Sample

Study Population

Members of the American College of Surgeons

Description

Inclusion Criteria:

• Members of the American College of Surgeons

Exclusion Criteria:

• None

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
American College of Surgeons members; Survey participants	Behavioral: Survey

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
Typical proportion of participants' patients given a recommendation to stop taking aspirin	At time of survey; generally less than 20 minutes
Proportion of participants correctly identifying national organizations with perioperative aspirin recommendations	At time of survey; generally less than 20 minutes
Proportion of participants correctly answering questions about platelet rebound effect	At time of survey; generally less than 20 minutes

Collaborators and Investigators

• Sponsor: University of New Mexico
• Investigators: Principal Investigator: Neal Gerstein, MD, University of New Mexico

Study record dates

Study Major Dates

• Study Start (Actual): October 1, 2015
• Primary Completion (Actual): April 1, 2016
• Study Completion (Actual): May 1, 2016

Study Registration Dates

• First Submitted: September 24, 2015
• First Submitted That Met QC Criteria: September 24, 2015
• First Posted (Estimated): September 28, 2015

Study Record Updates

• Last Update Posted (Estimated): January 8, 2024
• Last Update Submitted That Met QC Criteria: January 4, 2024
• Last Verified: January 1, 2024

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Cardiovascular Diseases
• Other Study ID Numbers: 15-215